MedTrace Logo

HR Versus RFA for HCC in Patients With PHT

NCT02192671 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2022-01-18

No results posted yet for this study

Summary

The purpose of the investigators' study is to prospectively compare the safety and efficacy of hepatic resection to radiofrequency ablation for hepatocellular carcinoma in patients with portal hypertension.

Conditions

  • Carcinoma, Hepatocellular
  • Liver Neoplasms
  • Neoplasms, Glandular and Epithelial

Interventions

PROCEDURE

Hepatic Resection

Indications for HR are the presence of appropriate residual liver volume determined by volumetric computed tomography.

PROCEDURE

Radiofrequency Ablation

Sponsors & Collaborators

  • Guangxi Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2022-08-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02192671 on ClinicalTrials.gov